Negócios · 21/09/20201 min de leitura
Investigational COVID-19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA or Agency) is announcing the withdrawal of a final guidance for industry entitled "Investigational COVID-19 Convalescent Plasma," which was issued in April 2020 and updated in May 2020. FDA is withdrawing the guidance because the Agency is issuing a new guidance for industry of the same title.